{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-23-003953","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.377332+00:00","generated_at":"2026-06-14T06:36:51.881612+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Organicell appoints Harry Leider as CEO and Howard Golub as CSO; Chairman Modi resigns","bullets":["Dr. Bhupendra Kumar Modi stepped down as Chairman and director on June 4, 2023.","Harry Leider, M.D., M.B.A., appointed CEO and board member; base salary $325k, option for 57M shares at $0.012.","Howard Golub, M.D., appointed EVP and Chief Science Officer; base salary $150k, part-time, option for 50M shares at $0.012.","Ian Bothwell continues as CFO, having served as interim CEO since Nov 2022.","Leider's option vests quarterly over 3 years; Golub's over 1 year; both have severance provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-23-003953","json":"https://secwatch.observer/filing/0001829126-23-003953.json","markdown":"https://secwatch.observer/filing/0001829126-23-003953.md","text":"https://secwatch.observer/filing/0001829126-23-003953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/organicellregen_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:36:51.881612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ca412577f","claim":"Harry Leider was appointed as Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"71d82db420","claim":"Howard J. Golub was appointed as Executive Vice President and Chief Science Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"and Howard J. Golub, M.D., as Executive Vice President and Chief Science Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Science Officer"}],"fact_type":"executive_change"},{"claim_id":"fb718282ec","claim":"Bhupendra Kumar Modi departed as Chairman of the Board at Zeo ScientifiX, Inc..","evidence_excerpt":"On June 4, 2023, Dr. Bhupendra Kumar Modi stepped down as Chairman of the Board and a director of Organicell.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}